• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Flexible Sensors Detect Heavy Metals in Sweat

      Flexible Sensors Detect Heavy Metals in Sweat

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Nanopore Sensor to Study Protein Aggregation in Neurodegeneration

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

    • Radiology
      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Ultrasound Tornado Rapidly Disrupts Blood Clots

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Fluorescence Imaging System Illuminates Tumor Depth

      Fluorescence Imaging System Illuminates Tumor Depth

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

    • Cardiology
      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Surgery
      Microneedle Bandage for Hemostatic Control

      Microneedle Bandage for Hemostatic Control

      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Nanomedicine
      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Magnetic Bacteria Target Tumors

      Magnetic Bacteria Target Tumors

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Implanted Magnets for Prosthetic Control

      Implanted Magnets for Prosthetic Control

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Antibody Drug Conjugates Market – 2019 Size, Potential Growth, Trends, Share, Key Players, Competitive Landscape, Regional Analysis With Global Forecast To 2023

July 17th, 2019 Market Research Future Releases

Antibody Drug Conjugates Market is expected to exhibit a strong 19% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). Global Antibody Drug Conjugates Market Driven by Growing Demand for Effective Cancer Medication. Antibody Drug Conjugates Market is segmented based on type, product, technology, application, end user, and region.

Competitive Analysis:

Leading players in the global antibody drug conjugates market include Oxford BioTherapeutics, Heidelberg Pharma, Synthon, Mersana Therapeutics, Progenics Pharmaceuticals, Astellas Pharma/Agensys, Bayer Healthcare, AbbVie Inc., Millennium Pharmaceuticals, Celldex Therapeutics, Pfizer Inc., Immunomedics, Antikor, Agensys Inc., Concortis Biotherapeutics, Genentech, Roche Holding AG, ImmunoGen Inc., and Seattle Genetics.

Get Free Sample “Antibody Drug Conjugate Market Research Report – Forecast to 2023” at: https://www.marketresearchfuture.com/sample_request/1113

The report provides readers with a comprehensive view of the global antibody drug conjugates market, enabling a complete understanding of the market’s major drivers and restraints for the readers. The major trends operating on the antibody drug conjugates market are also studied in detail in the report, providing readers with a clear picture of the dynamics within the market. Leading players in the global antibody drug conjugates market are also profiled in the report to provide readers with a clear view of the competitive dynamics of the market. Increasing Demand in Cancer Treatment to Drive Antibody Drug Conjugates Market

Antibody drug conjugates are a formulation in which specific antibodies can survive for long periods of time and deliver long-lasting, effective remedies against several diseases. The three parts of antibody drug conjugates are the antibody for binding, cytotoxic medical compounds for destroying the targeted cells, and a linker to join these two parts together and remain in a stable configuration. These formulations have become widely popular in the global healthcare sector as they represent a viable method of treating several diseases, including various types of cancers. The use of a specific antibody for binding to specific sites allows for highly targeted action of the medicine, while studies have shown that the cytotoxic agent is more than 100X as powerful when used in an antibody drug conjugate as when used in isolation.

The increasing demand for effective medications against cancer is likely to be the major driver for the global antibody drug conjugate market over the forecast period. Cancer research has emerged as a major driver for the healthcare sector, as the growing threat of cancer and the growing economic burden of the disease around the world has driven large-scale investment in the development of effective cancer medication. This is likely to drive further product development in the antibody drug conjugates market over the coming years, as leading players attempt to develop effective remedies for various types of cancer.

In July 2019, an early phase trial of patients with heavily pretreated HER2-related cancers showed promising activity from the antibody drug conjugate trastuzumab duocarmazine. The increasing range of the application of antibody drug conjugates is likely to be a key driver for the antibody drug conjugates market over the forecast period.

Segmentation:

The global antibody drug conjugate market is segmented based on type, product, technology, application, end user, and region.

Based on type, the global antibody drug conjugate market is segmented into monoclonal antibodies, linker, drug/toxin, and others.

Based on application, the global antibody drug conjugate market is segmented into leukemia, prostate cancer, kidney cancer, pancreatic cancer, ovary cancer, glioblastoma, lung cancer, colon cancer, breast cancer, skin cancer, solid tumors, multiple myeloma, lymphoma, and other cancers. The leukemia segment is further divided into acute myeloid leukemia (AML), chronic myeloid leukemia (CML), acute lymphocytic leukemia (ALL), and chronic lymphocytic leukemia (CLL).

Based on product, the global antibody drug conjugate market is segmented into Adcertis, Kadcyla, and others.

Based on technology, the global antibody drug conjugate market is classified into ImmunoGen technology, Seattle Genetics technology, Immunomedics technology, and others.

Based on end user, the global antibody drug conjugate market is classified into hospitals, specialized cancer centers, academic research institutes, biotechnology companies, biopharmaceutical companies, and others.

Regional Analysis:

The Americas hold the dominant share in the global antibody drug conjugates market due to the growing medical research industry in the region and the growing demand for effective cancer medication in the region. Europe is the second largest market, followed by Asia Pacific. The latter is expected to exhibit the fastest growth over the forecast period due to the growing healthcare sector and the increasing threat of cancer in this region.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Antibody Drug Conjugate Market, By Type

6.1 Introduction

6.2 Monoclonal Antibodies

6.2.1 Market Estimates & Forecast, 2017–2023

6.3 Linker

6.3.1 Market Estimates & Forecast, 2017–2023

6.4 Drug/Toxin

6.4.1 Market Estimates & Forecast, 2017–2023

6.5 Others

Chapter 7. Global Antibody Drug Conjugate Market, By Application

7.1 Introduction

7.2 Leukemia

7.2.1 Market Estimates & Forecast, 2017–2023

7.2.2 Acute Myeloid Leukemia (AML)

7.2.2.1 Market Estimates & Forecast, 2017–2023

7.2.3 Chronic Myeloid Leukemia (CML)

7.2.3.1 Market Estimates & Forecast, 2017–2023

7.2.4 Acute Lymphocytic Leukemia (ALL)

7.2.4.1 Market Estimates & Forecast, 2017–2023

7.2.5 Chronic Lymphocytic Leukemia (CLL)

7.2.5.1 Market Estimates & Forecast, 2017–2023

Continued…

LIST OF TABLES:

Table 1 Antibody Drug Conjugate Industry Synopsis, 2017–2023

Table 2 Antibody Drug Conjugate Market Estimates & Forecast, 2017–2023, (USD Million)

Table 3 Antibody Drug Conjugate Market, By Region, 2017–2023, (USD Million)

Table 4 Antibody Drug Conjugate Market, By Type, 2017–2023, (USD Million)

Table 5 Antibody Drug Conjugate Market, By Application, 2017–2023, (USD Million)

Table 6 Antibody Drug Conjugate Market, By Product, 2017–2023, (USD Million)

Table 7 Antibody Drug Conjugate Market, By Technology, 2017–2023, (USD Million)

Table 8 Antibody Drug Conjugate Market, By End-User, 2017–2023, (USD Million)

Continued…

LIST OF FIGURES:

Figure 1 Research Process

Figure 2 Segmentation For Antibody Drug Conjugate Market

Figure 3 Segmentation Market Dynamics For Antibody Drug Conjugate Market

Figure 4 Global Antibody Drug Conjugate Market Share, By Type, 2016

Figure 5 Global Antibody Drug Conjugate Market Share, By Application, 2016

Figure 6 Global Antibody Drug Conjugate Market Share, By Product, 2016

Figure 8 Global Antibody Drug Conjugate Market Share, By Technology, 2016

Figure 9 Global Antibody Drug Conjugate Market Share, By End-User, 2016

Figure 10 Global Antibody Drug Conjugate Market Share, By Region, 2016

Continued…

Browse more details at: https://www.marketresearchfuture.com/reports/antibody-drug-conjugate-market-1113

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Amanora Chambers,

Magarpatta Road, Hadapsar

Pune – 411028

Maharashtra, India+1 646 845 9312

sales@marketresearchfuture.com

Sign up and submit a press release

Sponsored
C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

C-mo Medical Solutions extends seed investment round to €4.8 million to transform cough monitoring

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

Fluidx Unveils New Embolic for Neurovascular Use

Fluidx Unveils New Embolic for Neurovascular Use

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

PT Genie Unveils New Brand Identity Reflecting Company’s Transformation and Focus on the Global Future of AI and Machine Learning in Digital Healthcare

interviews & reviews
Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email